Treatment for Candida in Urine
For symptomatic candiduria with fluconazole-susceptible organisms, treat with oral fluconazole 200 mg (3 mg/kg) daily for 2 weeks; for asymptomatic candiduria, do NOT treat with antifungals unless the patient is neutropenic, a very low-birth-weight infant (<1500g), or will undergo urologic manipulation. 1
Key Decision Algorithm
Step 1: Determine if Treatment is Indicated
Asymptomatic candiduria (most common scenario):
- Remove or replace urinary catheter if present - this is the single most important intervention 1
- Do NOT give antifungals in the vast majority of cases 1
- Spontaneous resolution occurs commonly after catheter removal 2
Exceptions requiring treatment despite no symptoms:
- Neutropenic patients → treat as candidemia 1
- Very low-birth-weight infants (<1500g) → treat as candidemia 1
- Patients undergoing urologic procedures → fluconazole 400 mg (6 mg/kg) daily OR amphotericin B deoxycholate 0.3-0.6 mg/kg daily for several days before and after the procedure 1
Step 2: For Symptomatic Patients - Identify the Site
Cystitis (lower tract symptoms):
- Fluconazole-susceptible species: Oral fluconazole 200 mg (3 mg/kg) daily for 2 weeks 1
- Fluconazole-resistant C. glabrata: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days OR oral flucytosine 25 mg/kg 4 times daily for 7-10 days 1
- C. krusei: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1
- Remove indwelling bladder catheter if feasible 1
Pyelonephritis (upper tract symptoms):
- Fluconazole-susceptible species: Oral fluconazole 200-400 mg (3-6 mg/kg) daily for 2 weeks 1
- Fluconazole-resistant C. glabrata: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days with or without oral flucytosine 25 mg/kg 4 times daily 1
- C. krusei: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1
- Eliminate urinary tract obstruction - this is critical 1
- Remove or replace nephrostomy tubes/stents if feasible 1
Critical Pitfalls to Avoid
Overtreatment is extremely common: Research shows that 23-24% of candiduria cases are managed inappropriately, with the majority being overtreated asymptomatic patients 3, 4. This leads to unnecessary antifungal exposure without clinical benefit 2, 5.
Fluconazole achieves short-term eradication but high recurrence rates: A landmark randomized trial showed fluconazole cleared candiduria by day 14 in 50% vs 29% with placebo, but by 2 weeks post-treatment, candiduria rates were similar between groups with no clinical benefit 2. This underscores why asymptomatic candiduria should not be treated.
Echinocandins are ineffective for candiduria: All echinocandins are poorly excreted in urine and should not be used for urinary tract candidiasis 6. They may be considered only for well-localized asymptomatic chorioretinitis in candidemia patients 7.
Candiduria rarely indicates disseminated candidiasis: Most candiduria represents colonization or localized infection, not systemic disease 6, 5. However, in neutropenic patients and very low-birth-weight infants, candiduria warrants treatment as candidemia due to higher dissemination risk 1.
Special Considerations
Catheter management is paramount: Catheter removal alone often resolves candiduria without antifungals 2. Studies show 52% eradication in catheterized patients completing fluconazole therapy vs 78% in non-catheterized patients 2.
Species identification matters: C. glabrata and C. krusei have intrinsic azole resistance patterns requiring amphotericin B-based regimens 1. Always obtain susceptibility testing when treating symptomatic candiduria.
Bladder irrigation option: For fluconazole-resistant cystitis (C. glabrata, C. krusei), amphotericin B deoxycholate bladder irrigation 50 mg/L sterile water daily for 5 days may be useful, though this is a weak recommendation 1.
Mortality and outcomes: Adherence to guidelines does not significantly affect mortality or clinical outcomes in most studies 4, 8, reinforcing that treatment should be reserved for truly symptomatic or high-risk patients only.